Schroder Investment Management Group
KYNB

Schroder Investment Management Group’s Kyntra Bio KYNB Stock Holding History

Schroder Investment Management Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-134,263
Closed -$9.06M – 1213
2023
Q2 		$9.06M Buy
134,263
+74,065
+123% +$30.6M 0.01% 656
2023
Q1 		$28.1M Sell
60,198
-10,232
-15% -$5.41M 0.04% 396
2022
Q4 		$28.2M Buy
70,430
+15,271
+28% +$5.85M 0.04% 380
2022
Q3 		$17.9M Sell
55,159
-7,460
-12% -$2.4M 0.03% 468
2022
Q2 		$17.1M Sell
62,619
-1,670
-3% -$427K 0.03% 503
2022
Q1 		$19.5M Buy
64,289
+11,731
+22% +$4.09M 0.03% 502
2021
Q4 		$18.5M Sell
52,558
-3,935
-7% -$1.23M 0.02% 483
2021
Q3 		$14.4M Buy
56,493
+14,081
+33% +$4.99M 0.02% 548
2021
Q2 		$28.2M Buy
42,412
+16,099
+61% +$9.27M 0.04% 442
2021
Q1 		$22.8M Buy
+26,313
New +$28M 0.03% 473

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group's KYNB Position: Q3 2023 in Review

Schroder Investment Management Group sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 134,263 shares — an estimated $9.06M sold.

Schroder Investment Management Group first reported a position in KYNB in Q1 2021 and held it in 10 quarters. The position peaked at $28.2M in Q2 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Schroder Investment Management Group reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 134,263 Kyntra Bio shares in Q3 2023, an estimated $9.06M.
  • Schroder Investment Management Group first reported a position in Kyntra Bio in Q1 2021 and held it in 10 quarters.
  • Schroder Investment Management Group's Kyntra Bio position peaked at $28.2M in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.